Home/Filings/4/0001415889-24-016663
4//SEC Filing

Jung Joel R 4

Accession 0001415889-24-016663

CIK 0001811115other

Filed

Jun 12, 8:00 PM ET

Accepted

Jun 13, 4:15 PM ET

Size

5.9 KB

Accession

0001415889-24-016663

Insider Transaction Report

Form 4
Period: 2024-06-11
Jung Joel R
Interim Chief Financial Office
Transactions
  • Award

    Employee Stock Option (right to buy)

    2024-06-11+60,00060,000 total
    Exercise: $0.21Exp: 2034-06-10Ordinary Shares (60,000 underlying)
Footnotes (2)
  • [F1]The exercise price is 0.1625 pounds sterling. The U.S. dollar equivalent of the exercise price is $0.2067 using the Bank of England rate as of June 10, 2024 (1.00 pound sterling = $1.272).
  • [F2]One fourth (1/4th) of the shares subject to the option award shall vest on August 28, 2024, and the remaining shares shall vest in nine equal monthly installments thereafter, subject to the Reporting Person's continuous service.

Issuer

Renalytix plc

CIK 0001811115

Entity typeother

Related Parties

1
  • filerCIK 0001373488

Filing Metadata

Form type
4
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 4:15 PM ET
Size
5.9 KB